Microcaps Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $18.7M

  • Investors
  • 10

Microcaps General Information

Description

Developer of a microencapsulation technology designed to protect pharmaceutical agents in drugs or fragrances in cosmetic products. The company offers a method to create liquid oil core microcapsules with a natural alginate shell and increase controlled microencapsulation production compared to conventional processes via a step emulsification device, enabling clients to achieve higher throughput rates without quality loss.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wagistrasse 13
  • 8952 Schlieren
  • Switzerland
+41 044
Primary Industry
Specialty Chemicals
Other Industries
Multi-line Chemicals
Vertical(s)
Corporate Office
  • Wagistrasse 13
  • 8952 Schlieren
  • Switzerland
+41 044

Microcaps Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microcaps Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 07-Jul-2026 $18.7M Completed Generating Revenue
11. Later Stage VC (Series A) 05-Jun-2024 Completed Generating Revenue
10. Seed Round 26-Jan-2021 Completed Generating Revenue
9. Seed Round 17-Jul-2019 Completed Generating Revenue
8. Accelerator/Incubator 15-May-2019 Completed Generating Revenue
7. Grant 15-Apr-2019 Completed Generating Revenue
6. Grant 01-Mar-2019 Completed Generating Revenue
5. Grant 01-Mar-2019 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2019 Completed Startup
3. Grant 06-Dec-2018 $150K Completed Startup
To view Microcaps’s complete valuation and funding history, request access »

Microcaps Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 33,334 $1.244267 $186.64 $186.64 1x $186.64 12.52%
To view Microcaps’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Microcaps Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a microencapsulation technology designed to protect pharmaceutical agents in drugs or fragrances in cosmeti
Specialty Chemicals
Schlieren, Switzerland
31 As of 2025

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microcaps Competitors (1)

One of Microcaps’s competitors is Aqdot, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aqdot Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Microcaps Patents

Microcaps Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025234704-A1 Capsule composition Pending 01-Mar-2024
WO-2025190674-A1 Capsule composition Pending 01-Mar-2024
EP-4654835-A1 Curing device for curing capsules Pending 26-Jan-2023
US-20260216672-A1 Curing device for curing capsules Pending 26-Jan-2023
WO-2024156534-A1 Curing device for curing capsules Inactive 26-Jan-2023 B01F23/41
To view Microcaps’s complete patent history, request access »

Microcaps Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microcaps Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Givaudan Corporation Minority
ETH Zürich Foundation Limited Partner Minority
Helvetica Capital Growth/Expansion Minority
Lichtsteiner Foundation Limited Partner Minority
Zürcher Kantonalbank Asset Manager Minority
You’re viewing 5 of 10 investors. Get the full list »

Microcaps FAQs

  • When was Microcaps founded?

    Microcaps was founded in 2018.

  • Where is Microcaps headquartered?

    Microcaps is headquartered in Schlieren, Switzerland.

  • What is the size of Microcaps?

    Microcaps has 31 total employees.

  • What industry is Microcaps in?

    Microcaps’s primary industry is Specialty Chemicals.

  • Is Microcaps a private or public company?

    Microcaps is a Private company.

  • What is the current valuation of Microcaps?

    The current valuation of Microcaps is .

  • What is Microcaps’s current revenue?

    The current revenue for Microcaps is .

  • How much funding has Microcaps raised over time?

    Microcaps has raised $35.1M.

  • Who are Microcaps’s investors?

    Givaudan, ETH Zürich Foundation, Helvetica Capital, Lichtsteiner Foundation, and Zürcher Kantonalbank are 5 of 10 investors who have invested in Microcaps.

  • Who are Microcaps’s competitors?

    Aqdot is a competitor of Microcaps.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process